請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/51284
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 閔明源(Ming-Yuan Min) | |
dc.contributor.author | Shi-Bing Wong | en |
dc.contributor.author | 王緒斌 | zh_TW |
dc.date.accessioned | 2021-06-15T13:29:26Z | - |
dc.date.available | 2021-03-08 | |
dc.date.copyright | 2016-03-08 | |
dc.date.issued | 2016 | |
dc.date.submitted | 2016-02-04 | |
dc.identifier.citation | Abdallah, D. M. (2010). 'Anticonvulsant potential of the peroxisome proliferator-activated receptor gamma agonist pioglitazone in pentylenetetrazole-induced acute seizures and kindling in mice.' Brain Res 1351: 246-253.
Adabi Mohazab, R., M. Javadi-Paydar, B. Delfan and A. R. Dehpour (2012). 'Possible involvement of PPAR-gamma receptor and nitric oxide pathway in the anticonvulsant effect of acute pioglitazone on pentylenetetrazole-induced seizures in mice.' Epilepsy Research 101(1–2): 28-35. Ahmadian, M., J. M. Suh, N. Hah, C. Liddle, A. R. Atkins, M. Downes and R. M. Evans (2013). 'PPARgamma signaling and metabolism: the good, the bad and the future.' Nat Med 19(5): 557-566. Alfstad, K. A., J. Clench-Aas, B. Van Roy, P. Mowinckel, L. Gjerstad and M. I. Lossius (2011). 'Psychiatric symptoms in Norwegian children with epilepsy aged 8-13 years: effects of age and gender?' Epilepsia 52(7): 1231-1238. An, S.-J., S.-K. Park, I. K. Hwang, S. Y. Choi, S. K. Kim, O.-S. Kwon, S. J. Jung, N.-I. Baek, H. Y. Lee, M. H. Won and T.-C. Kang (2003). 'Gastrodin decreases immunoreactivities of γ-aminobutyric acid shunt enzymes in the hippocampus of seizure-sensitive gerbils.' Journal of Neuroscience Research 71(4): 534-543. Avanzini, G. and S. Franceschetti (2003). 'Cellular biology of epileptogenesis.' Lancet Neurol 2(1): 33-42. Avoli, M. (1995). 'Feline generalized penicillin epilepsy.' Ital J Neurol Sci 16(1-2): 79-82. Avoli, M., M. D’Antuono, J. Louvel, R. Köhling, G. Biagini, R. Pumain, G. D’Arcangelo and V. Tancredi (2002). 'Network and pharmacological mechanisms leading to epileptiform synchronization in the limbic system in vitro.' Progress in Neurobiology 68(3): 167-207. Bell-Parikh, L. C., T. Ide, J. A. Lawson, P. McNamara, M. Reilly and G. A. FitzGerald (2003). 'Biosynthesis of 15-deoxy-delta12,14-PGJ2 and the ligation of PPARgamma.' J Clin Invest 112(6): 945-955. Berg, A. T., F. A. Zelko, S. R. Levy and F. M. Testa (2012). 'Age at onset of epilepsy, pharmacoresistance, and cognitive outcomes: a prospective cohort study.' Neurology 79(13): 1384-1391. Berretta, N., A. Ledonne, D. Mango, G. Bernardi and N. B. Mercuri (2012). 'Hippocampus versus entorhinal cortex decoupling by an NR2 subunit–specific block of NMDA receptors in a rat in vitro model of temporal lobe epilepsy.' Epilepsia 53(5): e80-e84. Buzsaki, G. and A. Draguhn (2004). 'Neuronal oscillations in cortical networks.' Science 304(5679): 1926-1929. Carta, A. R. (2013). 'PPAR-gamma: therapeutic prospects in Parkinson's disease.' Curr Drug Targets 14(7): 743-751. Cavus, I., W. S. Kasoff, M. P. Cassaday, R. Jacob, R. Gueorguieva, R. S. Sherwin, J. H. Krystal, D. D. Spencer and W. M. Abi-Saab (2005). 'Extracellular metabolites in the cortex and hippocampus of epileptic patients.' Ann Neurol 57(2): 226-235. Clifford, D. B., J. W. Olney, A. Maniotis, R. C. Collins and C. F. Zorumski (1987). 'The functional anatomy and pathology of lithium-pilocarpine and high-dose pilocarpine seizures.' Neuroscience 23(3): 953-968. Cormack, F., J. H. Cross, E. Isaacs, W. Harkness, I. Wright, F. Vargha-Khadem and T. Baldeweg (2007). 'The development of intellectual abilities in pediatric temporal lobe epilepsy.' Epilepsia 48(1): 201-204. Crino, Peter B., H. Jin, Melissa D. Shumate, Michael B. Robinson, Douglas A. Coulter and Amy R. Brooks-Kayal (2002). 'Increased Expression of the Neuronal Glutamate Transporter (EAAT3/EAAC1) in Hippocampal and Neocortical Epilepsy.' Epilepsia 43(3): 211-218. Cunliffe, V. T. 'Building a zebrafish toolkit for investigating the pathobiology of epilepsy and identifying new treatments for epileptic seizures.' Journal of Neuroscience Methods. Curia, G., D. Longo, G. Biagini, R. S. G. Jones and M. Avoli (2008). 'The pilocarpine model of temporal lobe epilepsy.' Journal of Neuroscience Methods 172(2): 143-157. Dai, J.-N., Y. Zong, L.-M. Zhong, Y.-M. Li, W. Zhang, L.-G. Bian, Q.-L. Ai, Y.-D. Liu, J. Sun and D. Lu (2011). 'Gastrodin Inhibits Expression of Inducible NO Synthase, Cyclooxygenase-2 and Proinflammatory Cytokines in Cultured LPS-Stimulated Microglia via MAPK Pathways.' PLoS ONE 6(7): e21891. de Moura, J. C., D. P. C. Tirapelli, L. Neder, F. P. Saggioro, A. C. Sakamoto, T. R. Velasco, R. A. Panepucci, J. P. Leite, J. A. Assirati, B. O. Colli and C. G. Carlotti (2012). 'Amygdala gene expression of NMDA and GABAA receptors in patients with mesial temporal lobe epilepsy.' Hippocampus 22(1): 92-97. Degos, V., S. Peineau, C. Nijboer, A. M. Kaindl, S. Sigaut, G. Favrais, F. Plaisant, N. Teissier, E. Gouadon, A. Lombet, E. Saliba, G. L. Collingridge, M. Maze, F. Nicoletti, C. Heijnen, J. Mantz, A. Kavelaars and P. Gressens (2013). 'G protein–coupled receptor kinase 2 and group I metabotropic glutamate receptors mediate inflammation-induced sensitization to excitotoxic neurodegeneration.' Annals of Neurology 73(5): 667-678. Doo, A. R., S. N. Kim, D. H. Hahm, H. H. Yoo, J. Y. Park, H. Lee, S. Jeon, J. Kim, S. U. Park and H. J. Park (2014). 'Gastrodia elata Blume alleviates L-DOPA-induced dyskinesia by normalizing FosB and ERK activation in a 6-OHDA-lesioned Parkinson's disease mouse model.' BMC Complement Altern Med 14: 107. During, M. J. and D. D. Spencer (1993). 'Extracellular hippocampal glutamate and spontaneous seizure in the conscious human brain.' Lancet 341(8861): 1607-1610. Dzhala, V. I., A. C. Brumback and K. J. Staley (2008). 'Bumetanide enhances phenobarbital efficacy in a neonatal seizure model.' Ann Neurol 63(2): 222-235. Eid, T., A. Ghosh, Y. Wang, H. Beckström, H. P. Zaveri, T.-S. W. Lee, J. C. K. Lai, G. H. Malthankar-Phatak and N. C. de Lanerolle (2008). 'Recurrent seizures and brain pathology after inhibition of glutamine synthetase in the hippocampus in rats.' Brain 131(8): 2061-2070. Eid, T., A. Williamson, T.-S. W. Lee, O. A. Petroff and N. C. De Lanerolle (2008). 'Glutamate and astrocytes—Key players in human mesial temporal lobe epilepsy?' Epilepsia 49: 42-52. Ermolyuk, Y. S., F. G. Alder, R. Surges, I. Y. Pavlov, Y. Timofeeva, D. M. Kullmann and K. E. Volynski (2013). 'Differential triggering of spontaneous glutamate release by P/Q-, N- and R-type Ca2+ channels.' Nat Neurosci 16(12): 1754-1763. Fan, X., W. Y. Jin and Y. T. Wang (2014). 'The NMDA receptor complex: a multifunctional machine at the glutamatergic synapse.' Frontiers in Cellular Neuroscience 8:160. Gao, H.-M., J. Jiang, B. Wilson, W. Zhang, J.-S. Hong and B. Liu (2002). 'Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease.' Journal of Neurochemistry 81(6): 1285-1297. Geerts, A., O. Brouwer, C. van Donselaar, H. Stroink, B. Peters, E. Peeters and W. F. Arts (2011). 'Health perception and socioeconomic status following childhood-onset epilepsy: the Dutch study of epilepsy in childhood.' Epilepsia 52(12): 2192-2202. Gloveli, T., D. Albrecht and U. Heinemann (1995). 'Properties of low Mg2+ induced epileptiform activity in rat hippocampal and entorhinal cortex slices during adolescence.' Developmental Brain Research 87(2): 145-152. Gnatkovsky, V., L. Librizzi, F. Trombin and M. de Curtis (2008). 'Fast activity at seizure onset is mediated by inhibitory circuits in the entorhinal cortex in vitro.' Ann Neurol 64(6): 674-686. Hamilton, S. E., M. D. Loose, M. Qi, A. I. Levey, B. Hille, G. S. McKnight, R. L. Idzerda and N. M. Nathanson (1997). 'Disruption of the m1 receptor gene ablates muscarinic receptor-dependent M current regulation and seizure activity in mice.' Proc Natl Acad Sci U S A 94(24): 13311-13316. Hamilton, S. E., M. D. Loose, M. Qi, A. I. Levey, B. Hille, G. S. McKnight, R. L. Idzerda and N. M. Nathanson (1997). 'Disruption of the m1 receptor gene ablates muscarinic receptor-dependent M current regulation and seizure activity in mice.' Proceedings of the National Academy of Sciences 94(24): 13311-13316. Hermann, B. P., M. Seidenberg, C. Dow, J. Jones, P. Rutecki, A. Bhattacharya and B. Bell (2006). 'Cognitive prognosis in chronic temporal lobe epilepsy.' Ann Neurol 60(1): 80-87. Hsieh, C.-L., C.-H. Chang, S.-Y. Chiang, T.-C. Li, N.-Y. Tang, C.-Z. Pon, C.-T. Hsieh and J.-G. Lin (2000). 'Anticonvulsive and free radical scavenging activities of vanillyl alcohol in ferric chloride-induced epileptic seizures in Sprague-Dawley rats.' Life Sciences 67(10): 1185-1195. Hu, Y., C. Li and W. Shen (2014). 'Gastrodin alleviates memory deficits and reduces neuropathology in a mouse model of Alzheimer's disease.' Neuropathology 34(4): 370-377. Jiang, G., H. Wu, Y. Hu, J. Li and Q. Li (2014). 'Gastrodin Inhibits Glutamate-Induced Apoptosis of PC12 Cells via Inhibition of CaMKII/ASK-1/p38 MAPK/p53 Signaling Cascade.' Cellular and Molecular Neurobiology 34(4): 591-602. Jiang, Q., M. Heneka and G. E. Landreth (2008). 'The role of peroxisome proliferator-activated receptor-gamma (PPARgamma) in Alzheimer's disease: therapeutic implications.' CNS Drugs 22(1): 1-14. Jin, M. M. and Z. Chen (2011). 'Role of gap junctions in epilepsy.' Neurosci Bull 27(6): 389-406. Kapadia, R., J. H. Yi and R. Vemuganti (2008). 'Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists.' Front Biosci 13: 1813-1826. Kilb, W., A. Sinning and H. J. Luhmann (2007). 'Model-specific effects of bumetanide on epileptiform activity in the in-vitro intact hippocampus of the newborn mouse.' Neuropharmacology 53(4): 524-533. Kim, H.-J., K.-D. Moon, S.-Y. Oh, S.-P. Kim and S.-R. Lee (2001). 'Ether fraction of methanol extracts of Gastrodia elata, a traditional medicinal herb, protects against kainic acid-induced neuronal damage in the mouse hippocampus.' Neuroscience Letters 314(1–2): 65-68. Kovács, R., A. Rabanus, J. Otáhal, A. Patzak, J. Kardos, K. Albus, U. Heinemann and O. Kann (2009). 'Endogenous Nitric Oxide Is a Key Promoting Factor for Initiation of Seizure-Like Events in Hippocampal and Entorhinal Cortex Slices.' The Journal of Neuroscience 29(26): 8565-8577. Krasowski, M. D. and G. A. McMillin (2014). 'Advances in anti-epileptic drug testing.' Clinica Chimica Acta 436: 224-236. Kwan, P. and M. J. Brodie (2000). 'Early Identification of Refractory Epilepsy.' New England Journal of Medicine 342(5): 314-319. Marsh, E. D., A. R. Brooks-Kayal and B. E. Porter (2006). 'Seizures and antiepileptic drugs: does exposure alter normal brain development?' Epilepsia 47(12): 1999-2010. Mody, I., J. D. Lambert and U. Heinemann (1987). 'Low extracellular magnesium induces epileptiform activity and spreading depression in rat hippocampal slices.' Journal of Neurophysiology 57(3): 869-888. Moreno, S., S. Farioli-Vecchioli and M. P. Cerù (2004). 'Immunolocalization of peroxisome proliferator-activated receptors and retinoid x receptors in the adult rat CNS.' Neuroscience 123(1): 131-145. Moser, J., W. Kilb, K. J. Werhahn and H. J. Luhmann (2006). 'Early developmental alterations of low-Mg2+ -induced epileptiform activity in the intact corticohippocampal formation of the newborn mouse in vitro.' Brain Res 1077(1): 170-177. Mrak, R. E. and G. E. Landreth (2004). 'PPARgamma, neuroinflammation, and disease.' J Neuroinflammation 1(1): 5. Nadler, J. V. (2003). 'The recurrent mossy fiber pathway of the epileptic brain.' Neurochem Res 28(11): 1649-1658. Nagao, T., A. Alonso and M. Avoli (1996). 'Epileptiform activity induced by pilocarpine in the rat hippocampal-entorhinal slice preparation.' Neuroscience 72(2): 399-408. Nenov, M. N., F. Laezza, S. J. Haidacher, Y. Zhao, R. G. Sadygov, J. M. Starkey, H. Spratt, B. A. Luxon, K. T. Dineley and L. Denner (2014). 'Cognitive Enhancing Treatment with a PPARγ Agonist Normalizes Dentate Granule Cell Presynaptic Function in Tg2576 APP Mice.' The Journal of Neuroscience 34(3): 1028-1036. Neuman, R. S., E. Cherubini and Y. Ben-Ari (1989). 'Endogenous and network bursts induced by N-methyl-D-aspartate and magnesium free medium in the CA3 region of the hippocampal slice.' Neuroscience 28(2): 393-399. Nickels, K. C., B. R. Grossardt and E. C. Wirrell (2012). 'Epilepsy-related mortality is low in children: a 30-year population-based study in Olmsted County, MN.' Epilepsia 53(12): 2164-2171. Nicolai, J., S. Ebus, D. P. Biemans, J. Arends, J. Hendriksen, J. S. Vles and A. P. Aldenkamp (2012). 'The cognitive effects of interictal epileptiform EEG discharges and short nonconvulsive epileptic seizures.' Epilepsia 53(6): 1051-1059. Nicolas, Céline S., S. Peineau, M. Amici, Z. Csaba, A. Fafouri, C. Javalet, Valerie J. Collett, L. Hildebrandt, G. Seaton, S.-L. Choi, S.-E. Sim, C. Bradley, K. Lee, M. Zhuo, B.-K. Kaang, P. Gressens, P. Dournaud, Stephen M. Fitzjohn, Zuner A. Bortolotto, K. Cho and Graham L. Collingridge (2012). 'The JAK/STAT Pathway Is Involved in Synaptic Plasticity.' Neuron 73(2): 374-390. Nissen, S. E. and K. Wolski (2007). 'Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes.' New England Journal of Medicine 356(24): 2457-2471. O'Callaghan, F. J., A. L. Lux, K. Darke, S. W. Edwards, E. Hancock, A. L. Johnson, C. R. Kennedy, R. W. Newton, C. M. Verity and J. P. Osborne (2011). 'The effect of lead time to treatment and of age of onset on developmental outcome at 4 years in infantile spasms: evidence from the United Kingdom Infantile Spasms Study.' Epilepsia 52(7): 1359-1364. Ojemann, L. M., W. L. Nelson, D. S. Shin, A. O. Rowe and R. A. Buchanan (2006). 'Tian ma, an ancient Chinese herb, offers new options for the treatment of epilepsy and other conditions.' Epilepsy & Behavior 8(2): 376-383. Oostrom, K. J., A. Smeets-Schouten, C. L. Kruitwagen, A. C. Peters, A. Jennekens-Schinkel and C. Dutch Study Group of Epilepsy in (2003). 'Not only a matter of epilepsy: early problems of cognition and behavior in children with 'epilepsy only'--a prospective, longitudinal, controlled study starting at diagnosis.' Pediatrics 112(6 Pt 1): 1338-1344. Ou, Z., X. Zhao, L. A. Labiche, R. Strong, J. C. Grotta, O. Herrmann and J. Aronowski (2006). 'Neuronal expression of peroxisome proliferator-activated receptor-gamma (PPARγ) and 15d-prostaglandin J2—Mediated protection of brain after experimental cerebral ischemia in rat.' Brain Research 1096(1): 196-203. Pancani, T., J. T. Phelps, J. L. Searcy, M. W. Kilgore, K. C. Chen, N. M. Porter and O. Thibault (2009). 'Distinct modulation of voltage-gated and ligand-gated Ca2+ currents by PPAR-gamma agonists in cultured hippocampal neurons.' J Neurochem 109(6): 1800-1811. Park, E. J., S. Y. Park, E.-h. Joe and I. Jou (2003). '15d-PGJ2 and Rosiglitazone Suppress Janus Kinase-STAT Inflammatory Signaling through Induction of Suppressor of Cytokine Signaling 1 (SOCS1) and SOCS3 in Glia.' Journal of Biological Chemistry 278(17): 14747-14752. Park, E. Y., I. J. Cho and S. G. Kim (2004). 'Transactivation of the PPAR-Responsive Enhancer Module in Chemopreventive Glutathione S-Transferase Gene by the Peroxisome Proliferator-Activated Receptor-γ and Retinoid X Receptor Heterodimer.' Cancer Research 64(10): 3701-3713. Petroff, O. A. C., D. L. Rothman, K. L. Behar and R. H. Mattson (1996). 'Low brain GABA level is associated with poor seizure control.' Ann Neurol 40(6): 908-911. Quilichini, P. P., D. Diabira, C. Chiron, Y. Ben-Ari and H. Gozlan (2002). 'Persistent epileptiform activity induced by low Mg2+ in intact immature brain structures.' European Journal of Neuroscience 16(5): 850-860. Racine, R. J. (1972). 'Modification of seizure activity by electrical stimulation. II. Motor seizure.' Electroencephalogr Clin Neurophysiol 32(3): 281-294. Rantanen, K., K. Eriksson and P. Nieminen (2011). 'Cognitive impairment in preschool children with epilepsy.' Epilepsia 52(8): 1499-1505. Rathouz, P. J., Q. Zhao, J. E. Jones, D. C. Jackson, D. A. Hsu, C. E. Stafstrom, M. Seidenberg and B. P. Hermann (2014). 'Cognitive development in children with new onset epilepsy.' Dev Med Child Neurol 56(7): 635-641. Regehr, W. G. (2012). 'Short-Term Presynaptic Plasticity.' Cold Spring Harbor Perspectives in Biology 4(7). Rektor, I., R. Kuba, M. Brazdil and J. Chrastina (2012). 'Do the basal ganglia inhibit seizure activity in temporal lobe epilepsy?' Epilepsy Behav 25(1): 56-59. Russ, S. A., K. Larson and N. Halfon (2012). 'A national profile of childhood epilepsy and seizure disorder.' Pediatrics 129(2): 256-264. Satriotomo, I., K. K. Bowen and R. Vemuganti (2006). 'JAK2 and STAT3 activation contributes to neuronal damage following transient focal cerebral ischemia.' Journal of Neurochemistry 98(5): 1353-1368. Selassie, A. W., D. A. Wilson, A. M. Malek, J. L. Wagner, G. Smith, G. Martz, J. Edwards, B. Wannamaker, M. M. Zack, R. Kobau, C. Centers for Disease and Prevention (2014). 'Premature deaths among children with epilepsy - South Carolina, 2000-2011.' MMWR Morb Mortal Wkly Rep 63(44): 989-994. Sillanpaa, M. and S. Shinnar (2010). 'Long-term mortality in childhood-onset epilepsy.' N Engl J Med 363(26): 2522-2529. Smolders, I., G. M. Khan, J. Manil, G. Ebinger and Y. Michotte (1997). 'NMDA receptor-mediated pilocarpine-induced seizures: characterization in freely moving rats by microdialysis.' British Journal of Pharmacology 121(6): 1171-1179. Staba, R. J. and A. Bragin (2011). 'High-frequency oscillations and other electrophysiological biomarkers of epilepsy: underlying mechanisms.' Biomark Med 5(5): 545-556. Stevanovic, D., J. Jancic and A. Lakic (2011). 'The impact of depression and anxiety disorder symptoms on the health-related quality of life of children and adolescents with epilepsy.' Epilepsia 52(8): e75-78. Stoppini, L., P. A. Buchs and D. Muller (1991). 'A simple method for organotypic cultures of nervous tissue.' Journal of Neuroscience Methods 37(2): 173-182. Sun, H., Y. Huang, X. Yu, Y. Li, J. Yang, R. Li, Y. Deng and G. Zhao (2008). 'Peroxisome proliferator-activated receptor gamma agonist, rosiglitazone, suppresses CD40 expression and attenuates inflammatory responses after lithium pilocarpine-induced status epilepticus in rats.' Int J Dev Neurosci 26(5): 505-515. Téllez-Zenteno, J. F. and L. Hernández-Ronquillo (2012). 'A Review of the Epidemiology of Temporal Lobe Epilepsy.' Epilepsy Research and Treatment 2012: 5. Taylor, J., A. Jacoby, G. A. Baker and A. G. Marson (2011). 'Self-reported and parent-reported quality of life of children and adolescents with new-onset epilepsy.' Epilepsia 52(8): 1489-1498. Traub, R., R. Miles and J. Jefferys (1993). 'Synaptic and intrinsic conductances shape picrotoxin-induced synchronized after-discharges in the guinea-pig hippocampal slice.' J Physiol 461: 525 - 547. Turski, W. A., E. A. Cavalheiro, M. Schwarz, S. J. Czuczwar, Z. Kleinrok and L. Turski (1983). 'Limbic seizures produced by pilocarpine in rats: behavioural, electroencephalographic and neuropathological study.' Behav Brain Res 9(3): 315-335. Upreti, C., R. Otero, C. Partida, F. Skinner, R. Thakker, L. F. Pacheco, Z.-y. Zhou, G. Maglakelidze, J. Velíšková, L. Velíšek, D. Romanovicz, T. Jones, P. K. Stanton and E. R. Garrido-Sanabria (2012). Altered neurotransmitter release, vesicle recycling and presynaptic structure in the pilocarpine model of temporal lobe epilepsy. Vasconcellos, E., E. Wyllie, S. Sullivan, L. Stanford, J. Bulacio, P. Kotagal and W. Bingaman (2001). 'Mental retardation in pediatric candidates for epilepsy surgery: the role of early seizure onset.' Epilepsia 42(2): 268-274. Wang, Q., G. Chen and S. Zeng (2008). 'Distribution and metabolism of gastrodin in rat brain.' Journal of Pharmaceutical and Biomedical Analysis 46(2): 399-404. Wieser, H. G. and I. C. o. N. o. Epilepsy (2004). 'ILAE Commission Report. Mesial temporal lobe epilepsy with hippocampal sclerosis.' Epilepsia 45(6): 695-714. Yu, X., X. G. Shao, H. Sun, Y. N. Li, J. Yang, Y. C. Deng and Y. G. Huang (2008). 'Activation of cerebral peroxisome proliferator-activated receptors gamma exerts neuroprotection by inhibiting oxidative stress following pilocarpine-induced status epilepticus.' Brain Res 1200: 146-158. Zhao, X., R. Strong, J. Zhang, G. Sun, J. Z. Tsien, Z. Cui, J. C. Grotta and J. Aronowski (2009). 'Neuronal PPARγ Deficiency Increases Susceptibility to Brain Damage after Cerebral Ischemia.' The Journal of Neuroscience 29(19): 6186-6195. Zhao, X., Y. Zou, H. Xu, L. Fan, H. Guo, X. Li, G. Li, X. Zhang and M. Dong (2012). 'Gastrodin protect primary cultured rat hippocampal neurons against amyloid-beta peptide-induced neurotoxicity via ERK1/2-Nrf2 pathway.' Brain Res 1482: 13-21. Zhou, Z., Y. Lin, H. Zheng, Y. He, H. Xu, S. Zhang, W. Weng, W. Li, L. Zhu and H. Yang (2015). 'Anticonvulsive and neuroprotective effects of synergetic combination of phenytoin and gastrodin on the convulsion induced by penicillin in mice.' Fundamental & Clinical Pharmacology 29(4): 371-381. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/51284 | - |
dc.description.abstract | 癲癇在孩童時期是一種常見的疾病,導因於腦部皮質的過度放電。不管是局部或泛發性的癲癇,反覆及長時間的發作都曾被證實會對個體的認知能力、情緒控制、學習能力會產生不好的影響。腦皮質的過度放電與皮質神經細胞的突觸傳遞相關。興奮性神經傳導物質的增強,如麩胺酸(glutamate),抑制性神經傳導物質的減弱,如γ-氨基丁酸(GABA),均可能造成皮質神經細胞同時間過度興奮而產生抽搐。反覆或長時間的癲癇發作,也會產生許多發炎介質和過氧化物,進而對組織造成二度傷害。因此,在治療上,平衡興奮性和抑制性的動作電位,如增強GABA 或抑制glutamate 的傳遞,以停止癲癇的進行,和減少癲癇所產生的發炎反應和過氧化物,都是目前研究的方向。在本論文中,我們發展出以低鎂溶液誘發海馬迴切片產生癲癇波的體外癲癇模式,另外也使用毛果芸香(Pilocarpine)腹腔注射在活體大鼠引發僵直痙攣性抽搐,這二種癲癇均被認為是經由N-甲基-D-天門冬胺酸受體(N-methyl-D-Aspartase, NMDA)受體激活所誘發出的痙攣。以這些癲癇實驗模式,我們測試了兩種藥物在癲癇上的療效,一為羅格列酮(rosiglitazone),另一為天麻苷(gastrodin)。
過氧化物增殖激活受體γ(PPARγ)是一種細胞核內的受體。羅格列酮是其中的一種激活劑(agonist),在毛果芸香誘導的癲癇發作具有神經保護效果。本實驗中發現10μM濃度的羅格列酮可顯著抑制海馬迴CA1神經元癲癇樣放電的頻率和幅度。併以PPARγ拮抗劑GW9662不能阻斷羅格列酮的抗痙攣效果。羅格列酮的能抑制海馬迴CA1-Schaffer collateral的突觸傳遞。通過微小興奮電位突觸電流(mEPSC)分析,羅格列酮顯著抑制突觸前神經傳導物質的釋放。這種現象可以被PPARγ拮抗劑GW9662阻止。此外,羅格列酮可減緩NMDA所造成的興奮性毒性。這個保護作用部分可被高劑量治療GW9662拮抗,表明該此保護效果部分是由PPARγ受體激活導致的。 天麻是一種古老的中國中草藥,是一種有效的抗驚厥藥和止痛藥,並具有抗眩暈,全身癱瘓,癲癇,破傷風和鎮靜的作用。主活性成分被稱為天麻苷,是4-羥基芐醇葡糖苷。天麻可以抑制缺氧,glutamate-,和N-甲基-D-天冬氨酸(NMDA)造成的神經毒性,並減少了癲癇發作的嚴重程度。 本實驗中發現25μM天麻苷可顯著抑制NMDA在海馬迴CA3造成的神經傷害。但天麻苷反而會加速腹腔注射毛果芸香的痙攣作用(P = 0.051)。天麻苷也未能抑制誘發低鎂誘發的癲癇樣放電。對於海馬迴突觸傳遞,天麻苷對興奮性突觸後電位(EPSP)沒有顯著效果。但高劑量天麻苷(200μM)可減少海馬迴雙刺激的促進效果(P = 0.002),暗示著高劑量天麻苷可能會影響細胞內鈣離子的存量。 結論上,羅格列酮可通過抑制突觸前神經傳導物質的釋放,來抑制NMDA受體所傳導的的癲癇樣放電。羅格列酮通過激活PPARγ來保護海馬切片抵抗NMDA的興奮性毒性。我們認為,羅格列酮有潛力可用來治療顳葉癲癇患者。另一種化合物天麻苷減緩癲癇的發生。天麻苷對神經突觸傳遞沒有影響。這些結果表明天麻苷無法以抑制NMDA受體傳遞的癲癇發生。但天麻苷仍表現出NMDA毒性的保護作用。因此,天麻苷對中風和癲癇患者的仍存潛在好處。 | zh_TW |
dc.description.abstract | Epilepsy is a common among childhood. Seizures are induced by synchronous discharges from cerebral cortex. Repetitive or prolonged seizures, either focal or generalized- origin, are proved to impair the individuals' cognition, emotion control and learning ability. The synchronous discharges of cerebral cortex based on imbalanced synaptic transmission, either enhanced excitatory neurotransmitter release, such as glutamate, or declined inhibitory neurotransmitter release, such as GABA. Repetitive or prolonged seizures may release many inflammatory cytokines and peroxides, and further lead to tissue injury. Thus, researches for seizure management focus on rebalancing of synaptic transmission, and reducing inflammatory or peroxide responses. In this dissertation, we introduced in vivo and in vitro seizure models to evaluate anti-convulsive properties for different chemicals. In vivo we applied pilocarpine intraperitoneally toward adult rats to induce generalized-tonic-clonic seizures. In vitro we incubated Mg2+-free medium toward acute hippocampal slices to provoke epileptiform discharges. Both of these were N-methyl-D-Aspartase receptor facilitated seizures. Two compounds were included in this dissertation, including rosiglitazone and gastrodin.
Peroxisomal proliferator-activated receptor gamma (PPARγ) is a nuclear hormone receptor whose agonist, rosiglitazone has a neuroprotective effect to hippocampal neurons in pilocarpine-induced seizures. Application of 10μM rosiglitazone significantly suppressed amplitude and frequency of epileptiform discharges in CA1 neurons. Pretreatment with the PPARγ antagonist GW9662 did not block the effect of rosiglitazone on suppressing discharge frequency, but reverse the effect on suppressing discharge amplitude. Application of rosiglitazone suppressed synaptic transmission in the CA1-Schaffer collateral pathway. By miniature excitatory-potential synaptic current (mEPSC) analysis, rosiglitazone significantly suppressed presynaptic neurotransmitter release. This phenomenon can be reversed by pretreating PPARγ antagonist GW9662. Also, rosiglitazone protected cultured hippocampal slices from NMDA-induced excitotoxicity. The protective effect of 10μM rosiglitazone was partially antagonized by concomitant high dose GW9662 treatment, indicating that this effect is partially mediated by PPARγ receptors. Tian ma (Gastrodia elata) is an ancient Chinese herbal medicine that has been suggested to be effective as an anticonvulsant and analgesic, and to have sedative effects against vertigo, general paralysis, epilepsy, and tetanus. The primary active ingredient isolated from G. elata has been termed gastrodin, which is the glucoside of 4-hydroxybenzyl alcohol. Gastrodin can abolish hypoxia-, glutamate-, and N-methyl-D-aspartate (NMDA) receptor-induced toxicity in primary cultures of rat cortical neurons, and reduces seizure severity in seizure-sensitive gerbils. Application of 25 μM gastrodin significantly suppressed NMDA excitotoxicity in CA3 hippocampus but not in CA1 hippocampus and dentate gyrus. Intraventricular gastrodin accelerated seizure onset for 12 min after intraperitoneal pilocarpine injection (P = 0.051). Three of five rats (60%) in the gastrodin group and three of four (75%) in the dimethyl sulfoxide (DMSO) group died within 3 days after status epilepticus. Gastrodin also failed to inhibit epileptiform discharges in hippocampal slices induced by Mg2+-free medium. The frequencies of the spontaneous epileptiform discharges were similar under gastrodin 25 μM, gastrodin 200 μM, and DMSO treatments. For the evaluation of gastrodin on synaptic transmission, application of DMSO, gastrodin 25 μM, or gastrodin 200 μM had no significant effect on excitatory postsynaptic potential (EPSP) slopes. Gastrodin 200 μM decreased paired-pulse facilitation from 1.23 ± 0.04 to 1.12 ± 0.04 (P = 0.002). In conclusion, rosiglitazone suppressed NMDA receptor-mediated epileptiform discharges by inhibition of presynaptic neurotransmitter release. Rosiglitazone protected hippocampal slice from NMDA excitotoxicity partially by PPARγ activation. We suggest that rosiglitazone could be a potential agent to treat patients with TLE. Another compound gastrodin failed to suppress in vivo and in vitro seizures in our study. Gastrodin showed no effect on hippocampal Schaffer collateral EPSP. These findings suggest that gastrodin does not interact with ionotropic glutamate receptors to inhibit NMDAR-facilitated seizures. But gastrodin showed protective effects against NMDA toxicity on cultured hippocampal slices. Nevertheless, gastrodin is still a potential neuroprotective agent against NMDA excitotoxicity, with potential benefits for stroke and patients with epilepsy. | en |
dc.description.provenance | Made available in DSpace on 2021-06-15T13:29:26Z (GMT). No. of bitstreams: 1 ntu-105-D98b41010-1.pdf: 1875098 bytes, checksum: 04995878ee29e14765968dbdad14c694 (MD5) Previous issue date: 2016 | en |
dc.description.tableofcontents | Contents
致謝…………………………………………………………………………………..….I 中文摘要……………………………………………………………………………….III Abstract………………………………………………………………………………...V Contents…………………………………………………………………………………IX Lists of Figures………………………………………………………………...……..XIII Introduction……………………………………………………………………………..1 i. Why do we work on epilepsy and how does epilepsy start?........................1 ii. Consequences of refractory seizures in children…………………………..6 iii. In vitro and in vivo seizure models………………………………………..8 iv. Aims of this dissertation………………………………………………….10 v. Chemicals investigated in this dissertation……………………………….11 Material and Methods………………………………………………………………….15 I. Animals…………………………………………………………………….15 II. Tissue preparation for electrophysiology experiments……………………..15 III. Lithium-pilocarpine-induced status epilepticus…………………..……….18 IV. Preparation of hippocampal slice cultures for neurotoxicity experiments…20 V. Propidium iodide fluorescence measurements……………………………..21 VI. Drugs……………………………………………………………………….21 VII. Data and statistical analysis………………………………………………...22 Results………………………………………………………………………………….24 I. Effect of rosiglitazone 10μM on epileptiform discharges in hippocampal slices induced by Mg2+ free ACSF…………………..…………………………..24 II. Effect of rosiglitazone 1μM/10μM on Schaffer collateral – CA1 synaptic transmission……………………………………………………………….27 III. Neuroprotection of rosiglitazone against excitotoxicity in hippocampal slice cultures…………………………………………………………………….29 IV. Gastrodin suppressed NMDA excitotoxicity in cultured hippocampal slices………………………………………………………………………31 V. Gastrodin failed to suppress status epilepticus induced by Lithium-pilocarpine in rats………………………...............………………..………………….33 VI. Gastrodin failed to reduce spontaneous epileptiform discharges induced by Mg2+-free medium…………….………………………………………….35 VII. Gastrodin showed no effect on synaptic transmission in the CA1-Schaffer collateral pathway………………………………………………………..37 Discussion…………………………………………………………………………….53 I. The effects of rosiglitazone on hippocampal synaptic transmission, NMDA toxicity and NMDA-facilitated in vitro seizures…………………………53 II. Rosiglitazone suppressed spike frequencies of NMDA-facilitated in vitro seizures but not spike amplitudes…………......………………………….54 III. Rosiglitazone suppressed hippocampal CA1-Schaffer collateral synaptic transmission via inhibition of presynaptic neurotransmitter release, which is possibly due to inhibition of voltage-gated calcium channels……………57 IV. Effects of PPARγ agonists for CNS disorders……………………………….58 V. Gastrodin protected cultured hippocampal tissue from NMDA toxicity, but failed to suppress in vivo and in vitro seizures………………...………….60 VI. The role of NMDA receptor in various CNS disorders and the possible mechanisms for gastrodin protection toward NMDA toxicity……...…….61 VII. The roles of Tian ma and gastrodin for treating seizures……...…………….63 Conclusion……………………………………………………………………………..67 Reference……………………………………………………………………………….69 | |
dc.language.iso | en | |
dc.title | 以電生理方式檢測抗痙攣藥物效果:羅格列酮和天麻苷對NMDA受體促進的體內及體外痙攣模式 | zh_TW |
dc.title | Electrophysiological Approaches for Screening
Anti-convulsants: Rosiglitazone and Gastrodin For The N-methyl-D-Aspartate Receptor-facilitated Seizures in vivo and in vitro | en |
dc.type | Thesis | |
dc.date.schoolyear | 104-1 | |
dc.description.degree | 博士 | |
dc.contributor.oralexamcommittee | 楊琇雯(Hsiu-Wen Yang),李旺祚(Wang-Tso Lee),林以文(Yi-Wen Lin),姜淑媛(Shu-Yuan Jiang) | |
dc.subject.keyword | 顳葉癲癇,羅格列酮,天麻?,神經保護,N-甲基-D-天冬氨酸, | zh_TW |
dc.subject.keyword | gastrodin,neuroprotection,NMDA receptor,rosiglitazone,temporal lobe seizure, | en |
dc.relation.page | 88 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2016-02-04 | |
dc.contributor.author-college | 生命科學院 | zh_TW |
dc.contributor.author-dept | 生命科學系 | zh_TW |
顯示於系所單位: | 生命科學系 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-105-1.pdf 目前未授權公開取用 | 1.83 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。